(Tesamorelin + CJC-1295 (No DAC) + Ipamorelin)
Growth Hormone Modulation • Metabolic Support • Recovery Optimization

Overview

• Synergistic peptide formulation combining:

  • Tesamorelin

  • CJC-1295 (No DAC)

  • Ipamorelin

• Designed to support endogenous growth hormone (GH) signaling

• Targets:

  • Metabolic balance

  • Tissue maintenance

  • Recovery pathways

  • Endocrine optimization

• Multi-mechanism approach to physiological, pulsatile GH release

• Integrates:

  • Long-acting GHRH analog

  • Short-acting GHRH analog

  • Selective ghrelin receptor agonist

• Mimics natural GH secretion patterns through complementary signaling pathways

Peptide Composition

• Tesamorelin

  • Stabilized Growth Hormone Releasing Hormone (GHRH) analog

  • Associated with endogenous GH stimulation

  • Supports metabolic and endocrine signaling pathways

• CJC-1295 (No DAC)

  • Short-acting GHRH analog

  • Promotes physiological, pulsatile GH release

• Ipamorelin

  • Selective ghrelin receptor (GHS-R1a) agonist

  • Stimulates GH release

  • Minimal effect on cortisol and prolactin pathways

Combined Activity

• Multi-pathway GH stimulation

• Endocrine balance support

• Cellular recovery signaling

• Metabolic adaptation support

Key Potential Benefits*

• Optimized Growth Hormone Output

  • Supports natural GH and IGF-1 signaling pathways

• Improved Recovery & Adaptation

  • Facilitates recovery following physical stress and training

• Growth Hormone Optimization

  • Encourages physiological GH release and downstream IGF-1 activity

• Lean Mass & Body Composition Support

  • GH-mediated pathways support muscle metabolism and fat utilization

• Synergistic Multi-Pathway Action

  • Integrates regenerative and endocrine mechanisms in one formulation

*As indicated in medical and research trials. Investigational outside approved medical indications.

Technical Information

CAS Numbers:

• Tesamorelin: 218949-48-5

• CJC-1295 (No DAC): 863288-34-0

• Ipamorelin: 170851-70-4

PubChem CIDs:

• Tesamorelin: 19243281

• CJC-1295 (No DAC): 25285409

• Ipamorelin: 10382169

Molecular Formulas:

• Tesamorelin: C₂₂₁H₃₆₆N₇₂O₆₇

• CJC-1295 (No DAC): C₁₅₂H₂₅₂N₄₄O₄₂

• Ipamorelin: C₃₈H₄₉N₉O₅

Synonyms:

• Tesamorelin, 218949-48-5, Egrifta, GHRH (1–44) acetate, stabilized GHRH peptide

• CJC-1295 (No DAC), Modified GRF (1-29), Mod GRF 1-29, 863288-34-0, GHRH analog

• Ipamorelin, IPA, NNC 26-0161, 170851-70-4, Growth Hormone Secretagogue, ghrelin receptor agonist, GHS-R1a agonist